INAB
Price
$2.25
Change
-$0.03 (-1.32%)
Updated
Aug 28, 04:55 PM (EDT)
Capitalization
10.26M
SRZN
Price
$11.52
Change
+$0.12 (+1.05%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
100.1M
Interact to see
Advertisement

INAB vs SRZN

Header iconINAB vs SRZN Comparison
Open Charts INAB vs SRZNBanner chart's image
IN8bio
Price$2.25
Change-$0.03 (-1.32%)
Volume$100
Capitalization10.26M
Surrozen
Price$11.52
Change+$0.12 (+1.05%)
Volume$440
Capitalization100.1M
INAB vs SRZN Comparison Chart in %
Loading...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INAB vs. SRZN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INAB is a StrongBuy and SRZN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (INAB: $2.28 vs. SRZN: $11.40)
Brand notoriety: INAB and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INAB: 51% vs. SRZN: 85%
Market capitalization -- INAB: $10.26M vs. SRZN: $100.1M
INAB [@Biotechnology] is valued at $10.26M. SRZN’s [@Biotechnology] market capitalization is $100.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INAB’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 1 green FA rating(s).

  • INAB’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 1 green, 4 red.
According to our system of comparison, SRZN is a better buy in the long-term than INAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INAB’s TA Score shows that 4 TA indicator(s) are bullish while SRZN’s TA Score has 2 bullish TA indicator(s).

  • INAB’s TA Score: 4 bullish, 3 bearish.
  • SRZN’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, INAB is a better buy in the short-term than SRZN.

Price Growth

INAB (@Biotechnology) experienced а +3.17% price change this week, while SRZN (@Biotechnology) price change was -0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRZN($100M) has a higher market cap than INAB($10.3M). SRZN YTD gains are higher at: -20.557 vs. INAB (-70.451). INAB has higher annual earnings (EBITDA): -20.28M vs. SRZN (-24.83M). SRZN has more cash in the bank: 90.4M vs. INAB (13.2M). INAB has less debt than SRZN: INAB (3.12M) vs SRZN (7.51M). SRZN has higher revenues than INAB: SRZN (12.6M) vs INAB (0).
INABSRZNINAB / SRZN
Capitalization10.3M100M10%
EBITDA-20.28M-24.83M82%
Gain YTD-70.451-20.557343%
P/E RatioN/AN/A-
Revenue012.6M-
Total Cash13.2M90.4M15%
Total Debt3.12M7.51M41%
TECHNICAL ANALYSIS
Technical Analysis
INABSRZN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SECCF3.12N/A
N/A
Serco Group Plc.
SUVPF229.00N/A
N/A
Sartorius AG
TAPM0.36N/A
N/A
Tapinator, Inc.
EAPIF3.09N/A
N/A
EUROAPI SA
NCXS65.00N/A
N/A
NBC Bancorp, Inc.

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
+1.79%
IDYA - INAB
47%
Loosely correlated
+0.56%
GRI - INAB
38%
Loosely correlated
+1.42%
SNSE - INAB
37%
Loosely correlated
+2.40%
CUE - INAB
35%
Loosely correlated
-1.71%
SRZN - INAB
28%
Poorly correlated
+2.70%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with IRON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+2.70%
IRON - SRZN
34%
Loosely correlated
+0.28%
ELDN - SRZN
32%
Poorly correlated
-1.34%
ABCZF - SRZN
28%
Poorly correlated
N/A
KMSTF - SRZN
27%
Poorly correlated
N/A
DWTX - SRZN
27%
Poorly correlated
-6.81%
More